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OBJECTIVE. To evaluate the feasibility of implementation of the refined window for routine antimicrobial prophylaxis (RAP) of 30-74 
minutes before skin incision compared to the World Health Organization (WHO) standard of 0-60 minutes. 
DESIGN. Prospective study on timing of routine antimicrobial prophylaxis in 2 different time periods. 
SETTING. Tertiary referral university hospital with 30,000 surgical procedures per year. 
METHODS. In all consecutive vascular, visceral, and trauma procedures, the timing was prospectively recorded during a first time period 
of 2 years (A; baseline) and a second period of 1 year (B; after intervention). An intensive intervention program was initiated after baseline. 
The primary outcome parameter was timing; the secondary outcome parameter was surgical site infection (SSI) rate in the subgroup of 
patients undergoing cholecystectomy/colon resection. 
RESULTS. During baseline time period A (3,836 procedures), RAP was administered 30-74 minutes before skin incision in 1,750 (41.0%) 
procedures; during time period B (1,537 procedures), it was administered in 914 (56.0%; P<.001). The subgroup analysis did not reveal 
a significant difference in SSI rate. 
CONCLUSIONS. This bundle of interventions resulted in a statistically significant improvement of timing of RAP even at a shortened 
window compared to the WHO standard. 
Infect Control Hosp Epidemiol 2012;33(9):912-916 
Surgical site infections (SSIs) significantly impact morbidity 
and mortality and represent a leading cause of healthcare-
attained infection.1"3 Appropriate perioperative antimicrobial 
prophylaxis can reduce the incidence of SSI.4"6 Today, single-
shot administration of a first- or second-generation cepha-
losporin is the state-of-the-art procedure in routine 
antimicrobial prophylaxis (RAP),7 supplemented with met-
ronidazole in colorectal surgery for anaerobic coverage. In 
addition to the type of antibiotic, the timing of RAP in re-
lation to skin incision is crucial. Based on the findings of the 
landmark publication in 1992 by Classen et al,8 guidelines 
recommend the administration of RAP within 2 hours before 
skin incision, whereas the 2008 World Health Organization 
(WHO) guidelines for safe surgery support administration 
within 1 hour before skin incision.9 In a prospective cohort 
study of 6,540 interventions, administration of RAP 30-74 
minutes before skin incision achieved the lowest SSI risk.10 
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Therefore, local guidelines were released in 2009 at Basel 
University Hospital recommending RAP within 30-74 
minutes. 
This study was conducted in a cohort of patients who 
underwent operations after implementation of these guide-
lines to assess whether they resulted in an improvement of 
RAP timing (primary outcome). Additionally, the study 
aimed at comparing the 2 time periods regarding the SSI rates 
in the subgroup of patients undergoing cholecystectomy and 
colon resection (secondary outcome). 
M E T H O D S 
Patients and Procedures 
During time period A (January 1, 2000, to December 31, 
2001) and time period B (April 1, 2009, to March 31, 2010), 
all consecutive surgical interventions performed in the vis-
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ceral, vascular, and trauma divisions at Basel University Hos-
pital were prospectively recorded. Operations involving no 
incision (closed reductions of joint dislocations), hospital stay 
of less than 24 hours, and procedures classified as dirty-
infected were excluded. Administration of RAP was based on 
Centers for Disease Control and Prevention (CDC) guidelines 
for surgical wound classification11 and was administered in 
class I (clean) wounds involving an implant (eg, hernia mesh 
repair, trauma surgery), class II (clean-contaminated) pro-
cedures (eg, colorectal, biliary surgery), and class III (con-
taminated) procedures when the source of infection was sur-
gically completely removed with no further need for antibiotic 
treatment. It consisted of single-shot cefuroxime in the case 
of colorectal surgery with coadministration of 500 mg met-
ronidazole and was repeated in the case of surgery exceeding 
4 hours. For time period A, baseline data were retrieved from 
the prospective observational study.10 The interval between 
administration of RAP and incision was compared between 
cohort A and cohort B. There was no change in practice of 
RAP over the investigated time periods. 
The SSI rate in the subgroup of all patients undergoing 
laparoscopic or open cholecystectomy and colon surgery was 
compared between the 2 periods. Cholecystectomy was rou-
tinely performed laparoscopically with the exception of con-
traindications for pneumoperitoneum, intraoperative com-
plications not easily manageable laparoscopically, or multiple 
previous surgeries with difficulties in establishing laparo-
scopic access, for which an open access/conversion was un-
dertaken. As for colon surgery, the majority was carried out 
by open surgery. SSI was prospectively assessed by an inde-
pendent team of infection control and prevention specialists 
and defined according to the guidelines of the CDC.11 The 
assessment was undertaken prospectively clinically for in-
patients and for outpatient follow-up by telephone (up to 5 
phone calls for contacting the patient and his or her family 
doctor, respectively) up to 30 days postoperatively. 
The study was approved by the human subject committee 
and was part of the continuous quality improvement pro-
gram, which was supported by the hospital executive board, 
as previously described.10 As an observational study within 
the quality improvement project, it was exempted from the 
written informed consent requirement. 
The 3 Interventions 
1. A consensus among all involved divisions was provided 
in oral and written form to all involved clinicians and pub-
lished on the hospital intranet. 
2. When applying for an operation room (OR) slot, the 
surgeons routinely had to indicate details on RAP, allowing 
the anesthesiologists to administer RAP prior to the surgeon 
being present in the OR and thus avoiding administration 
during the last 30 minutes before skin incision. The infor-
mation was mandatory; otherwise, the application could not 
be processed. Before the intervention, surgeons were able to 
provide this information in the OR, frequently not allowing 
sufficient time for optimal RAP. 
3. Anesthesiologists switched from a written chart to an 
electronic chart to record the time of RAP administration. 
Anesthesiologists were supported by the computer software 
that automatically reminded them to administer a second 
dose in cases of surgery exceeding 4 hours. 
Definitions 
The correct timing was defined (a) according to the Classen 
guidelines within 2 hours of prior incision,8 (b) according to 
the WHO guidelines within 1 hour,9 and (c) according to the 
local guidelines within 30-74 minutes.10 The comparison of 
SSI was performed (a) for all cholecystectomies/colon resec-
tions with the exception of class IV wounds and (b) for class 
I and II wounds only, since antibiotic prophylaxis for class 
III wounds may be regarded as preemptive therapy. 
Statistical Analysis 
Statistical analyses were performed using the t test or x2 test 
as appropriate. Two-tailed tests were used. A P value less than 
.05 was considered statistically significant. Statistical analyses 
were conducted with SPSS, version 19.0. 
RESULTS 
Baseline Characteristics 
During time periods A and B, a total of 10,095 consecutive 
invasive procedures (time period A, 6,540; time period B, 
3,555) were performed; 5,898/10,095 (58.4%) received RAP, 
4,265 during time period A and 1,633 during time period B. 
Of these, 67 (1.6%) and 87 (5.3%) procedures, respectively, 
received antibiotics more than 120 minutes before incision, 
3,836 (89.9%) and 1,537 (94.1%) within 120 minutes, and 
362 (8.5%) and 9 (0.6%) after incision. 
Data on baseline characteristics are listed in Table 1. 
Whereas the American Society of Anesthesiologists classifi-
cation did not differ between the 2 periods, there was a small 
but significant decrease in mean age and an increase in body 
mass index (BMI). In addition, there was a relative increase 
of vascular procedures and a decrease of trauma procedures, 
a higher number of clean wounds, and a lower number of 
emergency procedures over time. In period A, 417 (10.9%) 
patients had a BMI greater than 30 as compared to 284 
(18.5%) in period B. 
Comparison of Timing of RAP between the 2 Periods 
The impact of the intervention program was significant; the 
relative increase in compliance to this refined window of 
application was 36%. A significant increase in timing within 
120 minutes before incision was found, as well as a trend 
toward more frequent administration within 60 minutes be-
fore incision (Table 2). Overall, the RAP was administered at 
a median of 30.0 minutes (interquartile range [IQR], 
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15.0-45.0) before surgery and 34.3 minutes (IQR, 20.0-49.7) 
after the intervention. In elective procedures, RAP was ad-
ministered at a median of 30.0 minutes (IQR, 15.0-45.0) in 
time period A and improved to 39.1 (IQR, 27-52) in time 
period B, whereas in emergency procedures RAP was ad-
ministered at a median of 25.0 (IQR, 15.0-40.0) and 24.2 
(IQR, 15-38) minutes for period A and B, respectively. Re-
garding intraoperative redosing for procedures at least 4 hours 
in time period A (n = 310; 8.1%), redosing was performed 
in 136 (43.9%) procedures, whereas in time period B (n — 
58; 3.8%), redosing was performed in 22 (37.9%). 
Emergency Procedures as Compared to 
Elective Procedures 
Emergency procedures were performed in 1,253 cases (29.4%) 
during period A and 271 (16.6%) during period B. The cor-
rect timing, as referred to 30-74 minutes, improved signifi-
cantly over time in elective procedures from 1,277 (42.4%) 
to 816 (59.9%) procedures (relative risk reduction of 41%; 
P< .001), whereas in emergency procedures, timing was op-
timal in time period A in 473 (37.7%) procedures as com-
pared to 98 (36.2%) procedures in B (relative risk reduction 
of —4%), without statistical significance (P = .625; Table 2). 
SSI Rate after Cholecystectomy and Colon 
Surgery (Subgroup Analysis) 
After excluding wound class IV, a total of 483 interventions 
(242 cholecystectomies, 241 colon surgeries) were performed 
in period A. Out of these, 44 developed an SSI (9.1%), 17 
(7%) after cholecystectomy and 27 (11%) after colon surgery. 
During period B, 257 interventions (164 cholecystectomies, 
93 colon surgery) were performed. Out of these, 25 developed 
an SSI (11.35%), 9 (5.5%) after cholecystectomy and 16 
(17.25%) after colon surgery. 
There was no significant difference in SSI rates between 
the 2 time periods (P = .535 for cholecystectomy, P = 
.428 for colon surgery). When excluding wound classes III 
and IV, the overall SSI rate did not show any significant 
difference between the 2 time periods. 
DISCUSSION 
This study demonstrates an improvement of optimal timing 
of RAP administration according to international (0-2 hours 
prior to incision8'9) and local (30-74 minutes10) guidelines 
after implementation of an intervention program to optimize 
timing of RAP in a university teaching hospital. In a subset 
of cholecystectomy and colon resection patients, there was 
no difference in SSI rate before versus after the implemen-
tation of these guidelines. 
Since 1992, the international guidelines of correct timing 
of RAP were based on the landmark publication by Classen 
et al8 recommending timing within 2 hours before skin in-
cision. In August 2008, the WHO guidelines9 recommending 
administration within 1 hour prior to skin incision were pub-
lished as a report of the World Alliance for Patient Safety. 
At Basel University Hospital, new guidelines were imple-
TABLE l. Summary of Characteristics by Surgical Procedure of the 2 Study Populations at the 2 
Different Time Intervals 
Characteristics 
Mean age ( ± SD), years 
Female gender 
Mean BMI ( ± SD), kg/m2 
Division of surgical specialty 
Visceral surgery 
Traumatology 
Vascular surgery 
ASA score 
1 
2 
3 
4 
5 
Unknown 
Wound classification 
I 
II 
III 
Emergency procedure 
Yes 
No 
Time period A (n = 4,265) 
59.1 (19.2) 
2,079 (48.7) 
25.0 (4.8) 
1,643 (38.5) 
1,936 (45.4) 
686 (16.1) 
562 (13.2) 
2,006 (47.0) 
1,487 (34.9) 
201 (4.7) 
9 (0.2) 
2,996 (70.2) 
762 (17.9) 
507 (11.9) 
1,253 (29.4) 
3,012 (70.6) 
Time period B (« = 1,633) 
57.3 (18.6) 
781 (47.8) 
26.2 (5.2) 
609 (37.3) 
617 (37.8) 
407 (24.9) 
201 (12.3) 
766 (46.9) 
575 (35.2) 
72 (4.4) 
6 (0.4) 
13 (0.8) 
1,288 (78.9) 
210 (12.9) 
135 (8.3) 
271 (16.6) 
1,362 (83.4) 
P 
.001 
.527 
<C.001 
.384 
<.001 
<.001 
.373 
.930 
.803 
.619 
.285 
<.001 
<.001 
<.001 
<.001 
<.001 
NOTE. All data are no. (%) unless otherwise indicated. ASA, American Society of Anesthesiologists; 
BMI, body mass index; SD, standard deviation. 
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TABLE 2. Summary of the Different Time Intervals of Prophy-
lactic Antibiotic Administration of the 2 Study Populations for 
All Procedures, Elective and Emergency Procedures 
Guidelines (time interval), 
minutes 
0-120 0-60 30-74 
All procedures 
Time period A (« = 
Time period B (« = 
Absolute RR, % 
Relative RR, % 
P 
Elective procedures 
Time period A (« = 
Time period B (n = 
Absolute RR, % 
Relative RR, % 
P 
Emergency procedures 
Time period A (n = 
Time period B (n = 
Absolute RR, % 
Relative RR, % 
4,265), 
1,633), 
3,012), 
1,362), 
1,235), 
% 
% 
% 
% 
% 
271), % 
89.9 
94.1 
4.2 
5 
<.001 
90.6 
95.0 
4.4 
5 
<.001 
88.4 
89.7 
1.2 
1 
81.8 
83.6 
1.8 
2 
.099 
82.2 
83.3 
1.2 
1 
.349 
80.8 
84.9 
4.1 
5 
41.0 
56.0 
14.9 
36 
<.001 
42.4 
59.9 
17.5 
41 
<001 
37.7 
36.2 
-1.6 
- 4 
P .560 .115 .625 
NOTE. RR, risk reduction. 
mented recommending an optimal window of 30-74 minutes 
before skin incision, referring to the published data by Weber 
et al10 in 2008. The results of this study show a statistically 
significant improvement of optimal timing overall and for 
elective surgery within this time frame after implementation 
of the new guidelines. Covering a time period of 12 months, 
this is likely to be a change in routine clinical practice rather 
than a short-term reaction to newly introduced guidelines.1213 
Although this improvement from 41% to 56% is statistically 
significant, there is an urgent need for additional strategies 
to improve administration within this time window and for 
validation of better outcomes in terms of SSI rates for the 
respective time window in a larger sample. We therefore plan 
to conduct a large randomized controlled trial to evaluate the 
optimal timing of RAP in terms of SSI as primary outcome. 
This study will be adequately constructed to deliver high-level 
evidence on the optimal timing. 
The fact that no improvement was found for emergency 
surgery may be explained by the nature of emergency pro-
cedures, for which priority is given to immediately lifesaving 
interventions. Nevertheless, optimal timing remains impor-
tant in emergency procedures as well, and improvement will 
require good interdisciplinary communication and standard-
ized guidelines accounting for priorities in the emergency 
situation. 
Concerning redosing, it is known that redosing of anti-
biotic prophylaxis in operations of at least 4 hours decreases 
the SSI risk.14 The compliance to these recommendations was 
low in both time periods. Although the rate is comparable 
with other published data,15 measures should be implemented 
to improve adequate redosing. An electronic reminder, which 
was installed during time period B in our operating theater, 
was helpful but frequently noticed only at the end of surgery. 
Combining it with an acoustic reminder would be a possibility 
to improve redosing. 
The SSI rate after cholecystectomy and colon surgery was 
similar to the SSI rate found in literature, with up to 5.68% 
for cholecystectomy and 11.52% for colorectal surgery.16 Con-
versely, Smith et al17 found a rate of incisional SSI after elective 
colorectal resections of 26.5%. Despite the significant im-
provement of RAP within the refined window, the SSI rate 
did not decrease between time period A and time period B. 
A similar result was observed by Hawn et al.18 We hypothesize 
that the additional benefit of improved prophylaxis requires 
a larger sample size to detect small but clinically important 
differences, especially in patients undergoing elective chole-
cystectomy with a fairly low risk for SSI. This is also supported 
by the fact that there was only a small difference of 4.4 
minutes in median time before incision between the 2 time 
periods. Additionally, prophylaxis was highly standardized 
and was not adapted to high BMIs. Moreover, other risk 
factors such as Staphylococcus aureus carriage19 and the lack 
of checklists20 possibly diminished the effects of RAP. Addi-
tionally, point prevalence studies performed routinely once 
or twice yearly by the infection control department clearly 
show a general trend for a continuous increase of nosocomial 
infections, likely representing the selection of seriously ill pa-
tients referred to the university hospital. Therefore, a stable 
incidence of SSIs may be considered a considerable success 
in an infection control program. 
This study has several limitations. First, the prospective 
documentation of timing of RAP was manual in period A 
and electronic in period B. However, we do not assume an 
impact on the timing or its documentation, as previously 
described in a retrospective cohort study.21 Second, the SSI 
rate was studied in only a subset of patients. The subset of 
patients with cholecystectomy and colon resection was chosen 
as a sample for quality control in clean and clean-contami-
nated wounds. However, the SSI rate might have differed if 
other interventions had been accounted for. 
In conclusion, our study showed the improvement of tim-
ing of RAP within 30-74 minutes prior to skin incision after 
implementation of new guidelines without change in SSI rates 
after cholecystectomy and colon resection. After further im-
provement of timing, a randomized-controlled trial will pro-
vide high-level evidence about optimal timing. 
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